두개내압 모니터링 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 기술별, 용도별, 지역별, 부문 예측(2025-2030년)
Intracranial Pressure Monitoring Devices Market Size, Share & Trends Analysis Report By Technique (Invasive, Non-invasive), By Application (Traumatic Brain Injury, Intracerebral Hemorrhage), By Region, And Segment Forecasts, 2025 - 2030
상품코드
:
1750838
리서치사
:
Grand View Research
발행일
:
2025년 05월
페이지 정보
:
영문 100 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
샘플 요청 목록에 추가
두개내압 모니터링 디바이스 시장의 성장과 동향 :
Grand View Research, Inc.의 최신 리포트에 따르면 세계의 두개내압 모니터링 디바이스 시장은 2030년까지 28억 5,000만 달러에 달할 것으로 예측되며, 2025-2030년에 CAGR 7.9%로 확대할 것으로 예측됩니다.
시장 성장의 주요 촉진요인은 최소 침습 수술의 채택 증가, 외상 치료에 대한 높은 수요, 기술 발전입니다.
의료 서비스 프로바이더들의 첨단 장비 및 기술 솔루션 도입에 대한 관심이 높아지고 여러 지역에서 의료비 지출이 증가하면서 유리한 기회를 창출할 것으로 예측됩니다. 효과적인 헬스케어 기술에 대한 수요와 뇌 및 척수 관련 복잡한 질환을 앓고 있는 환자들에게 제공되는 중환자 치료와 관련된 솔루션에 대한 요구가 증가하면서 기술 혁신과 기술 진보를 촉진하고 있습니다. 조직과 정부의 R&D 활동에 대한 대규모 투자, 주요 기업의 최신 기술을 통한 새로운 제품 개발 지향, 외상 및 손상으로 인한 치료 증가는 추가적인 성장을 창출할 것으로 예측됩니다.
두개내압 모니터링 디바이스 시장 보고서 하이라이트
침습적 두개내압 모니터링 디바이스 부문이 세계 산업을 지배합니다. 이 부문은 2024년 75.0% 이상의 매출 점유율을 차지했으며, 이는 이 부문이 제공하는 높은 정확도와 중환자 치료에서 적절한 장비 설치의 필요성 때문입니다.
비침습적 두개내압 모니터링 기기 분야는 예측 기간 중 CAGR 10.0%로 가장 빠른 성장세를 보일 것으로 예측됩니다.
경두개 도플러 초음파 검사 장비는 2025-2030년 사이 큰 성장이 예상됩니다.
외상성 뇌손상(TBI) 부문은 2024년 가장 큰 매출 점유율을 차지했습니다.
북미는 미국, 캐나다와 같은 국가의 정교한 의료 시스템의 존재, 외상으로 인한 부상 및 뇌졸중 발생률 증가, 비침습적 의료 기술에 대한 수요 증가로 인해 2024년 북미가 세계 업계를 지배했습니다.
목차
제1장 조사 방법과 범위
제2장 개요
제3장 세계의 두개내압 모니터링 디바이스 시장의 변수, 동향 및 범위
시장 계통 전망
시장 역학
시장 성장 촉진요인 분석
시장 성장 억제요인 분석
세계의 두개내압 모니터링 디바이스 시장 분석 툴
업계 분석 - Porter's Five Forces 분석
PESTLE 분석
제4장 세계의 두개내압 모니터링 디바이스 시장 : 기술 비즈니스 분석
테크닉 부문 대시보드
두개내압 모니터링 디바이스 시장 : 변동 분석
세계의 두개내압 모니터링 디바이스 시장 규모와 동향 분석(2018-2030년)
침습적
EVD(External Ventricular Drainage)
마이크로트랜스듀서 두개내압 모니터링
비침습적
경두개 도플러 초음파 검사
고막 변위(TMD)
시신경초경
MRI/CT
안저 검사
제5장 세계의 두개내압 모니터링 디바이스 시장 : 용도 비즈니스 분석
애플리케이션 부문 대시보드
두개내압 모니터링 디바이스 시장 : 변동 분석
세계의 두개내압 모니터링 디바이스 시장 규모와 동향 분석(2018-2030년)
외상성 뇌손상
뇌내 출혈
수막염
지주막하 출혈
뇌척수액 관리
편두통
뇌졸중
수두증
뇌파
기타
제6장 세계의 두개내압 모니터링 디바이스 시장 : 지역 추정·동향 분석
지역 시장 대시보드
지역별 시장 점유율 분석, 2024년 및 2030년
지역별 세계의 두개내압 모니터링 디바이스 시장 : 주요 포인트
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
남아프리카공화국
사우디아라비아
아랍에미리트
쿠웨이트
제7장 경쟁 구도
주요 시장 참여 기업에 의한 최근 동향과 영향 분석
기업/경쟁 분류
벤더 구도
기업 개요
Medtronic
Integra LifeSciences
RAUMEDIC AG
Sophysa
Spiegelberg GmbH &Co. KG.(Luciole Medical AG)
Natus Medical
Digitimer Ltd
NeuraSignal, Inc.
KSA
영문 목차
Intracranial Pressure Monitoring Devices Market Growth & Trends:
The global intracranial pressure monitoring devices market is anticipated to reach USD 2.85 billion by 2030 and is anticipated to expand at a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary driving factors for market growth are the increasing adoption of minimally invasive surgeries, high demand in trauma care, and technological advancements.
Increasing focus of healthcare service providers on adopting sophisticated devices and technology solutions, and growth in healthcare expenditure across multiple regions are expected to generate lucrative opportunities. Demand for effective health management techniques and the growing requirement for solutions associated with critical care offered for patients experiencing complex conditions related to the brain or spinal cord has been stimulating innovation and technological advancements. Significant investments in research and development activities by organizations and governments, inclination among key players to develop novel products powered by modern technology capabilities, and increasing trauma or injury-driven treatments are anticipated to create further growth.
Intracranial Pressure Monitoring Devices Market Report Highlights:
The invasive intracranial pressure monitoring devices segment dominated the global industry. It accounted for a revenue share of more than 75.0% in 2024, owing to the accuracy offered by techniques, and the requirement of adequate device placements in critical care.
Non-invasive intracranial pressure monitoring devices segment is expected to experience the fastest CAGR of 10.0% during the forecast period.
Transcranial Doppler Ultrasonography devices are anticipated to experience significant growth from 2025 to 2030.
The Traumatic Brain Injury (TBI) segment held the largest revenue share in 2024.
North America dominated the global industry in 2024, owing to the presence of sophisticated healthcare systems in countries such as the U.S. and Canada, growing incidence of trauma-driven injuries and strokes, and rising demand for non-invasive healthcare technologies.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technique
1.2.2. Application
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR's Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technique Outlook
2.2.2. Application Outlook
2.2.3. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Intracranial Pressure Monitoring Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Global Intracranial Pressure Monitoring Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter's Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Global Intracranial Pressure Monitoring Devices Market: Technique Business Analysis
4.1. Technique Segment Dashboard
4.2. Intracranial Pressure Monitoring Devices Market: Technique Movement Analysis
4.3. Global Intracranial Pressure Monitoring Devices Market Size & Trend Analysis, By Technique, 2018 to 2030 (USD Million)
4.4. Invasive
4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2. External Ventricular Drainage (EVD)
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3. Microtransducer ICP Monitoring
4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.4. Non-invasive
4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.5. Transcranial Doppler Ultrasonography
4.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.6. Tympanic Membrane Displacement (TMD)
4.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.7. Optic Nerve Sheath Diameter
4.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.8. MRI/CT
4.4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.9. Fundoscopy
4.4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Global Intracranial Pressure Monitoring Devices Market: Application Business Analysis
5.1. Application Segment Dashboard
5.2. Intracranial Pressure Monitoring Devices Market: Application Movement Analysis
5.3. Global Intracranial Pressure Monitoring Devices Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
5.4. Traumatic Brain Injury
5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Intracerebral Hemorrhage
5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6. Meningitis
5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7. Subarachnoid Hemorrhage
5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.8. CSF Management
5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.9. Migraine
5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.10. Stroke
5.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.11. Hydrocephalus
5.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.12. EEG
5.12.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.13. Others
5.13.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Global Intracranial Pressure Monitoring Devices Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2030
6.3. Global Intracranial Pressure Monitoring Devices Market by Region: Key Takeaways
6.4. North America
6.4.1. U.S.
6.4.1.1. Key Country Dynamics
6.4.1.2. Regulatory Framework/ Reimbursement Structure
6.4.1.3. Competitive Scenario
6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Canada
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework/ Reimbursement Structure
6.4.2.3. Competitive Scenario
6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Mexico
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework/ Reimbursement Structure
6.4.3.3. Competitive Scenario
6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. Europe
6.5.1. Germany
6.5.1.1. Key Country Dynamics
6.5.1.2. Regulatory Framework/ Reimbursement Structure
6.5.1.3. Competitive Scenario
6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework/ Reimbursement Structure
6.5.2.3. Competitive Scenario
6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework/ Reimbursement Structure
6.5.3.3. Competitive Scenario
6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework/ Reimbursement Structure
6.5.4.3. Competitive Scenario
6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework/ Reimbursement Structure
6.5.5.3. Competitive Scenario
6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.6. Russia
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework/ Reimbursement Structure
6.5.6.3. Competitive Scenario
6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Regulatory Framework/ Reimbursement Structure
6.6.1.3. Competitive Scenario
6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. China
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework/ Reimbursement Structure
6.6.2.3. Competitive Scenario
6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.3. India
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework/ Reimbursement Structure
6.6.3.3. Competitive Scenario
6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.4. Australia
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework/ Reimbursement Structure
6.6.4.3. Competitive Scenario
6.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.5. Thailand
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework/ Reimbursement Structure
6.6.5.3. Competitive Scenario
6.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework/ Reimbursement Structure
6.6.6.3. Competitive Scenario
6.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.7. Singapore
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework/ Reimbursement Structure
6.6.7.3. Competitive Scenario
6.6.7.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Regulatory Framework/ Reimbursement Structure
6.7.1.3. Competitive Scenario
6.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Colombia
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework/ Reimbursement Structure
6.7.2.3. Competitive Scenario
6.7.2.4. Colombia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework/ Reimbursement Structure
6.7.3.3. Competitive Scenario
6.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8. Middle East & Africa
6.8.1. South Africa
6.8.1.1. Key Country Dynamics
6.8.1.2. Regulatory Framework/ Reimbursement Structure
6.8.1.3. Competitive Scenario
6.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework/ Reimbursement Structure
6.8.2.3. Competitive Scenario
6.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework/ Reimbursement Structure
6.8.3.3. Competitive Scenario
6.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.4. Kuwait
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework/ Reimbursement Structure
6.8.4.3. Competitive Scenario
6.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. Key Company Heat Map Analysis, 2024
7.4. Company Profiles
7.4.1. Medtronic
7.4.1.1. Company Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Integra LifeSciences
7.4.2.1. Company Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. RAUMEDIC AG
7.4.3.1. Company Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Sophysa
7.4.4.1. Company Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Spiegelberg GmbH & Co. KG. (Luciole Medical AG)
7.4.5.1. Company Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Natus Medical
7.4.6.1. Company Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Digitimer Ltd
7.4.7.1. Company Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. NeuraSignal, Inc.
7.4.8.1. Company Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
관련자료